Comparison of perioperative complications for extended vs standard pelvic lymph node dissection in patients undergoing radical prostatectomy for prostate cancer: a meta-analysis
- PMID: 35528467
- PMCID: PMC9077149
Comparison of perioperative complications for extended vs standard pelvic lymph node dissection in patients undergoing radical prostatectomy for prostate cancer: a meta-analysis
Abstract
Introduction: Pelvic lymph node dissection (PLND) is widely performed for staging in men undergoing radical prostatectomy (RP) for prostate cancer. Our goal was to synthesize all available evidence and data to evaluate perioperative complications for two templates of PLND, standard (sPLND) vs extended (ePLND), at the time of RP in patients with prostate cancer.
Methods: A meta-analysis was performed on relevant literature about complications during PLND. Pubmed, Scopus, WebofScience, and Cochrane Library were systematically searched through July 2021. Meta-analysis was conducted with both fixed-effects and random-effects models to estimate risk ratios (RRs) between treatments. A subgroup analysis was also conducted based on surgery type - open vs robotic.
Results: 13 (1 randomized clinical trial and 12 observational studies) studies published between 1997 and 2019 with a total of 7,036 patients were analyzed. Pooled data showed complications in a random-effects model was lower in the sPLND group than the ePLND group (RR, 0.62; 95% CI 0.40-0.97). In a subgroup analysis, neither the open surgery subgroup nor the robotic surgery subgroup showed significant differences in complication rate between sPLND and ePLND.
Conclusion: ePLND is associated with a significantly greater risk of perioperative complication compared to sPLND, but not when comparing these templates performed via a robotic approach. Additional studies comparing the complication rates of sPLND and ePLND when utilizing a robotic approach should be conducted.
Keywords: Prostate cancer; complications; extended pelvic lymph node dissection; pelvic lymph node dissection; pelvic lymphadenectomy; radical prostatectomy.
AJCEU Copyright © 2022.
Conflict of interest statement
None.
Figures




Similar articles
-
A comparative analysis of perioperative complications and biochemical recurrence between standard and extended pelvic lymph node dissection in prostate cancer patients undergoing radical prostatectomy: a systematic review and meta-analysis.Int J Surg. 2024 Mar 1;110(3):1735-1743. doi: 10.1097/JS9.0000000000000997. Int J Surg. 2024. PMID: 38052016 Free PMC article.
-
Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy.World J Urol. 2013 Jun;31(3):481-8. doi: 10.1007/s00345-013-1056-9. Epub 2013 Mar 20. World J Urol. 2013. PMID: 23512231
-
Extended versus standard pelvic lymph node dissection yields no difference in 3-year biochemical recurrence rates.Prostate Int. 2023 Jun;11(2):107-112. doi: 10.1016/j.prnil.2022.12.005. Epub 2022 Dec 21. Prostate Int. 2023. PMID: 37409090 Free PMC article.
-
Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer.BJU Int. 2010 Aug;106(4):537-42. doi: 10.1111/j.1464-410X.2009.09161.x. Epub 2010 Feb 3. BJU Int. 2010. PMID: 20132202
-
Which lymph node dissection template is optimal for radical cystectomy? A systematic review and Bayesian network meta-analysis.Front Oncol. 2022 Nov 25;12:986150. doi: 10.3389/fonc.2022.986150. eCollection 2022. Front Oncol. 2022. PMID: 36505883 Free PMC article.
Cited by
-
Metastatic lymph nodes outside the extended lymphadenectomy template correlate with advanced staging but not grading in prostate cancer patients undergoing radical prostatectomy.Int Urol Nephrol. 2025 Sep;57(9):2799-2810. doi: 10.1007/s11255-025-04450-0. Epub 2025 Mar 15. Int Urol Nephrol. 2025. PMID: 40088356 Free PMC article.
-
Utility of Machine Learning Models to Predict Lymph Node Metastasis of Japanese Localized Prostate Cancer.Cancers (Basel). 2024 Dec 5;16(23):4073. doi: 10.3390/cancers16234073. Cancers (Basel). 2024. PMID: 39682259 Free PMC article.
References
-
- Briganti A, Blute ML, Eastham JH, Graefen M, Heidenreich A, Karnes JR, Montorsi F, Studer UE. Pelvic lymph node dissection in prostate cancer. Eur Urol. 2009;55:1251–1265. - PubMed
-
- Palapattu GS, Singer EA, Messing EM. Controversies surrounding lymph node dissection for prostate cancer. Urol Clin North Am. 2010;37:57–65. - PubMed
-
- Sood A, Keeley J, Palma-Zamora I, Dalela D, Arora S, Peabody JO, Rogers CG, Montorsi F, Menon M, Briganti A, Abdollah F. Extended pelvic lymph-node dissection is independently associated with improved overall survival in patients with prostate cancer at high-risk of lymph-node invasion. BJU Int. 2020;125:756–758. - PubMed
-
- Chen J, Wang Z, Zhao J, Zhu S, Sun G, Liu J, Zhang H, Zhang X, Shen P, Shi M, Zeng H. Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database. Sci Rep. 2019;9:17985. - PMC - PubMed
-
- Fergany A, Kupelian PA, Levin HS, Zippe CD, Reddy C, Klein EA. No difference in biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients. Urology. 2000;56:92–95. - PubMed
Publication types
LinkOut - more resources
Full Text Sources